Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy

Schroder, 2012, Landmarks in prostate cancer screening, BJU Int, 110, 3, 10.1111/j.1464-410X.2012.011428.x Koo, 2013, Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5alpha-reductase inhibitors, Prostate Int, 1, 102, 10.12954/PI.13022 Basch, 2012, Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion, J Clin Oncol, 30, 3020, 10.1200/JCO.2012.43.3441 Presti, 2003, Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study, J Urol, 169, 125 Koh, 2015, Additional targeted biopsy in clinically suspected prostate cancer: prospective randomized comparison between contrast-enhanced ultrasound and sonoelastography guidance, Ultrasound Med Biol, 41, 2836, 10.1016/j.ultrasmedbio.2015.06.024 Carroll, 2014, Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines, J Natl Compr Canc Netw, 12, 1211, 10.6004/jnccn.2014.0120 Welch, 2007, Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era, J Natl Cancer Inst, 99, 1395, 10.1093/jnci/djm119 Carter, 1992, Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease, Cancer Res, 52, 3323 Kim, 2015, Can prostate-specific antigen kinetics before prostate biopsy predict the malignant potential of prostate cancer?, Yonsei Med J, 56, 1492, 10.3349/ymj.2015.56.6.1492 Carter, 2007, Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability, Urology, 70, 685, 10.1016/j.urology.2007.05.010 Ulmert, 2008, J Clin Oncol, 26, 835, 10.1200/JCO.2007.13.1490 Celhay, 2007, Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?, BJU Int, 99, 1028, 10.1111/j.1464-410X.2007.06752.x Taverna, 2009, PSA repeatedly fluctuating levels are reassuring enough to avoid biopsy?, Arch Ital Urol Androl, 81, 203 Park, 2014, Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy, Prostate Int, 2, 26, 10.12954/PI.13037 Boddy, 2004, Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies, BJU Int, 93, 735, 10.1111/j.1464-410X.2003.04717.x Marberger, 2012, Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study, BJU Int, 109, 1162, 10.1111/j.1464-410X.2011.10373.x van Leeuwen, 2011, Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies, Eur Urol, 59, 183, 10.1016/j.eururo.2010.09.035 Nazir, 2014, Pain during transrectal ultrasound-guided prostate biopsy and the role of periprostatic nerve block: what radiologists should know, Korean J Radiol, 15, 543, 10.3348/kjr.2014.15.5.543 Birs, 2016, Diagnosis and monitoring of prostatic lesions: a comparison of three modalities: multiparametric MRI, fusion MRI/transrectal ultrasound (TRUS), and traditional TRUS, Cureus, 8, e702 Franiel, 2011, Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding–multiparametric MR imaging for detection and biopsy planning, Radiology, 259, 162, 10.1148/radiol.10101251 Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520 Kongnyuy, 2016, Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: review of technology, techniques, and outcomes, Curr Urol Rep, 17, 32, 10.1007/s11934-016-0589-z Pepe, 2016, Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer, Clin Genitourin Cancer